Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma (mRCC). [electronic resource]
Producer: 20170214Description: 406-14 p. digitalISSN:- 2972-4066
- Angiogenesis Inhibitors -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Axitinib
- Bevacizumab -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Everolimus -- therapeutic use
- Humans
- Imidazoles -- therapeutic use
- Indazoles -- therapeutic use
- Indoles -- therapeutic use
- Interferon-alpha -- administration & dosage
- Interleukin-2 -- therapeutic use
- Kidney Neoplasms -- pathology
- Nephrectomy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Pyrimidines -- therapeutic use
- Pyrroles -- therapeutic use
- Singapore
- Sirolimus -- analogs & derivatives
- Sorafenib
- Sulfonamides -- therapeutic use
- Sunitinib
No physical items for this record
Publication Type: Journal Article; Practice Guideline
There are no comments on this title.
Log in to your account to post a comment.